Functionalized drugs and polymers derived therefrom

A compound selected from the group consisting of:

• wherein DRUG-OH, DRUG-COOH and DRUG-NH2 are compounds selected from the group consisting of NSAIDs (non-steroidal anti-inflammatory drugs) and pain-reducing agents;
• wherein each X represents a member independently selected from the group consisting of:
• —CH2COO— (glycolic acid moiety),
• —CH(CH3)COO— (lactic acid moiety),
• —CH2CH2OCH2COO— (dioxanone moiety),
• —CH2CH2CH2CH2CH2COO— (caprolactone moiety),
• —(CH2)yCOO— where y is one of the numbers 2,3,4 or 6-24 inclusive, and
• —(CH2CH2O)zCH2COO— where z is an integer between 2 and 24, inclusive;
• each Y represents a member independently selected from the group consisting of:
• —COCH2O— (glycolic ester moiety),
• —COCH(CH3)O— (lactic ester moiety),
• —COCH2OCH2CH2O— (dioxanone ester moiety),
• —COCH2CH2CH2CH2CH2O— (caprolactone ester moiety),
• —CO(CH2)mO— where m is an integer between 2-4 and 6-24 inclusive,
• —COCH2—O(CH2CH2O)n— where n is an integer between 2 and 24, inclusive;
• and
• R′ is hydrogen, benzyl or an alkyl group, the alkyl group being either straight-chained or branched;
• and p is an integer between 1 and 4, inclusive.